Mary Kay Fenton

Chief Financial Officer

Chief Financial Officer at Cullinan Therapeutics, Inc., filing insider transactions on 2026-02-20.

Total Purchases

—

0 transactions

Total Sales

$60K

1 transaction

Companies Traded

1 total filings

Active Since

2026-02-20

Last: 2026-02-20

Companies

Cullinan Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-20	CGEM	Sale	4,398	$13.62	$60K	126.4K	SEC ↗